Is Bamlanivimab effective in the treatment of COVID-19?
TreatmentsA: Currently, the evidence is not yet clear, and we need lots more data. The FDA issued an Emergency Use Authorization (EUA) for bamlanivimab use in non-hospitalized patients with mild to moderate COVID-19 on November 9th. Bamlanivimab is a neutralizing monoclonal antibody that targets the spike protein on the SARS-CoV-2 virus. The goal of neutralizing …